Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -97.81x is 89% above its 4-year average of -883.75x, near the high end of its 4-year range (-3621.00x–-17.29x).
69.07% below its 12-month average of -57.85x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2026 (2026-06-30): -70.50x.
INTEREST COVERAGE RATIO
-97.81x
INTEREST COVERAGE RATIO AVG TTM
-57.85x
INTEREST COVERAGE RATIO AVG 3Y
-1245.57x
INTEREST COVERAGE RATIO AVG 5Y
-883.75x
INTEREST COVERAGE RATIO AVG 10Y
-13.53x
INTEREST COVERAGE RATIO AVG 15Y
-4.11x
INTEREST COVERAGE RATIO AVG 20Y
-3.13x
CURRENT VS TTM AVG
-69.07%
CURRENT VS 3Y AVG
+92.15%
CURRENT VS 5Y AVG
+88.93%
CURRENT VS 10Y AVG
-623.03%
CURRENT VS 15Y AVG
-2281.86%
CURRENT VS 20Y AVG
-3022.56%
SECTOR MEDIAN · HEALTHCARE
-5.65x
median of 459 covered companies
CURRENT VS SECTOR MEDIAN
-1631.15%
vs the sector median at left
GT Biopharma, Inc.
Market Cap
$7.93M
Interest Coverage Ratio
-97.81x
TTM Avg
-57.85x
3Y Avg
-1245.57x
5Y Avg
-883.75x
Market Cap
$7.95M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.11M
Interest Coverage Ratio
-11.17x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.12M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$7.62M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.25M
Interest Coverage Ratio
-17.73x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$8.48M
Interest Coverage Ratio
-17.26x
TTM Avg
23.36x
3Y Avg
23.36x
5Y Avg
23.36x
Market Cap
$7.37M
Interest Coverage Ratio
-1049.68x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | $7.93M | -97.81x | -57.85x | -1245.57x | -883.75x |
| ENDRA Life Sciences Inc. (NDRA)vs › | $7.95M | N/A | N/A | N/A | N/A |
| HeartSciences Inc. (HSCS)vs › | $8.11M | -11.17x | N/A | N/A | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.12M | N/A | N/A | N/A | N/A |
| Quince Therapeutics, Inc. (QNCX)vs › | $7.62M | N/A | N/A | N/A | N/A |
| DataMEDS AI, Inc. (MEDS)vs › | $8.25M | -17.73x | N/A | N/A | N/A |
| Healthcare Triangle, Inc. (HCTI)vs › | $8.48M | -17.26x | 23.36x | 23.36x | 23.36x |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.37M | -1049.68x | N/A | N/A | N/A |
| Longeveron Inc. (LGVN)vs › | $7.33M | N/A | N/A | N/A | N/A |
| InMed Pharmaceuticals Inc. (INM)vs › | $7.31M | -924.78x | N/A | N/A | N/A |
Interest Coverage
-97.8x
Debt/Equity
0.00
Current Ratio
2.61
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-06-30 | -70.50x |
| 2026-03-31 | -45.21x |
| 2023-06-30 | -3621.00x |
| 2023-03-31 | -17.29x |
| 2022-12-31 | -722.25x |
| 2021-12-31 | -826.27x |
| 2021-03-31 | -41.67x |
| 2020-12-31 | 0.75x |
| 2020-09-30 | -2.09x |
| 2020-06-30 | -0.33x |
| 2020-03-31 | -1.68x |
| 2019-12-31 | -1.36x |
| 2019-09-30 | -15.81x |
| 2019-06-30 | -4.76x |
| 2019-03-31 | -8.93x |
| 2018-12-31 | -2.71x |
| 2018-09-30 | -208.96x |
| 2018-06-30 | -1.31x |
| 2018-03-31 | -2.44x |
| 2017-12-31 | -43.64x |
| 2017-09-30 | -33.66x |
| 2017-06-30 | -1.09x |
| 2017-03-31 | -0.44x |
| 2016-12-31 | -0.46x |
| 2016-09-30 | -1.65x |
| 2016-06-30 | -1.33x |
| 2016-03-31 | -2.37x |
| 2015-12-31 | -0.41x |
| 2015-09-30 | -1.61x |
| 2015-06-30 | -1.69x |
| 2015-03-31 | -0.24x |
| 2014-12-31 | -1.08x |
| 2014-09-30 | -0.17x |
| 2014-06-30 | -0.62x |
| 2014-03-31 | -0.51x |
| 2013-12-31 | -1.20x |
| 2013-09-30 | -0.65x |
| 2013-06-30 | -0.29x |
| 2013-03-31 | -0.65x |
| 2012-12-31 | -2.12x |
| 2012-09-30 | -20.77x |
| 2012-06-30 | -0.88x |
| 2012-03-31 | -5.36x |
| 2011-12-31 | -11.52x |
| 2011-09-30 | -4.62x |
| 2011-06-30 | -2.67x |
| 2011-03-31 | -11.06x |
| 2010-12-31 | -5.79x |
| 2010-09-30 | -28.43x |
| 2010-06-30 | -32.17x |
| 2010-03-31 | -2.35x |
| 2009-12-31 | -0.95x |
| 2009-09-30 | -0.64x |
| 2009-06-30 | -1.42x |
| 2009-03-31 | -1.45x |
| 2008-09-30 | -0.39x |
| 2008-06-30 | 1.17x |
| 2008-03-31 | -1.96x |
